“…Participants with myocardial infarction were enrolled in four trials, 6,9,11,20 myocardial infarction or revascularization in four trials, 8,10,12,13 coronary artery disease in one trial. 8 Three trials 8,12,14 enrolled patients with only low or moderate risk for future cardiac events (Table 1). Patients with heart failure, severe arrhythmias, ischemia and severe comorbidities were excluded.…”